音頻丨格隆匯5.16盤前要點—港A美股你需要關注的大事都在這
格隆匯5月16日丨1、納指漲近4%領漲三大指數 但本週均跌超2% 熱門中概股走強;
2、橋水一季度建倉伯克希爾 清倉特斯拉 增持多隻新興市場ETF和阿里ADR;
3、本週資本市場大事提醒;
4、中國4月社融增量9102億 新增人民幣貸款6454億;
5、上海:5月16日將分階段推動復商復市;
6、國家衞健委:要在大城市建立步行15分鐘核酸“採樣圈”;
7、香港:2022年GDP增長預測向下修訂至1%至2%;
8、中國央行:4月份住户貸款減少2170億元,同比少增7453億元;
9、知名經濟學家警吿新興經濟體:小心“經濟、能源、糧食和債務危機”同時發生;
10、中國結算:4月新增投資者數125.67萬 環比下降45.41%;
11、中證協報吿透露個人投資者最新數據:股民超1.97億 基民超7.2億;
12、證監會發布《證券公司科創板股票做市交易業務試點規定》;
13、本週超1100億市值解禁 “快遞茅”定增股東浮虧逾25億;
14、央行銀保監會祭出“大招”!房貸利率可低至4.4%,貸款50萬未來30年可節省利息2萬元;
15、央行、銀保監會:首套房房貸利率下限調整為不低於相應期限貸款市場報價利率減20個基點;
16、東莞出台樓市新政:二孩三孩家庭放寬購房 獲證滿2年可交易;
17、2023年亞足聯亞洲盃將易地舉辦;
18、即將交付的首架C919大飛機首飛試驗成功;
19、三星正在就將芯片製造價格提高20%進行磋商;
20、組件再漲!價格或將再返2元時代;
21、印度宣佈禁止小麥出口;
22、三天兩板真視通:為上海浦東新區承建部分核酸採樣工作站 訂單預計收入佔2022年營收的3%-5%;
23、眾生藥業:口服抗新冠病毒創新藥RAY1216臨牀試驗獲批;
24、雲康集團(2325.HK)將於本週三上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.